Sleep is a vital function of the human body, and a lack of sleep can have serious implications on physical and mental health. For those who suffer from chronic insomnia, the search for a safe and effective sleep aid can be a frustrating one. Hydroxyzine, an antihistamine used to treat allergies and anxiety, is increasingly being used as an off-label treatment for insomnia. In this article, we will examine the potential benefits of hydroxyzine for sleep, as well as the optimal dosage for maximal effectiveness.
Hydroxyzine is an antihistamine used to treat symptoms of allergies and anxiety. It is available in both oral and injectable forms, and is sold under various brand names, including Atarax, Vistaril, and Anxanil. Hydroxyzine works by blocking histamine receptors, which helps to reduce inflammation and anxiety. It is also known to have sedative effects, which makes it an attractive option for those seeking relief from insomnia.
Hydroxyzine has been shown to be effective in treating insomnia in both short-term and long-term studies. In a double-blind, placebo-controlled study of patients with chronic insomnia, hydroxyzine was found to be more effective than a placebo in improving sleep quality and duration. In another study, hydroxyzine was found to be more effective than diphenhydramine, another antihistamine, in improving sleep quality and reducing daytime sleepiness. Hydroxyzine also has the advantage of being less likely to cause next-day drowsiness than other sleep aids. This is due to its long half-life, which means that it remains active in the body for a longer period of time. This makes it an attractive option for those who need to be able to function during the day.
The optimal dosage of hydroxyzine for sleep will vary depending on the individual. Generally, the recommended dosage is 25-50 mg taken at bedtime. However, some individuals may need higher doses, up to 100 mg per night. It is important to note that hydroxyzine should not be taken for more than two weeks at a time, as it can lead to tolerance and dependence.
Hydroxyzine is generally well-tolerated, but it can cause some side effects, including dry mouth, drowsiness, dizziness, and constipation. It can also interact with other medications, so it is important to discuss any potential interactions with your doctor before taking hydroxyzine.
Hydroxyzine is an effective and safe option for those looking for relief from insomnia. It is generally well-tolerated and less likely to cause next-day drowsiness than other sleep aids. The optimal dosage will vary depending on the individual, but is generally 25-50 mg taken at bedtime. It is important to speak to your doctor before taking hydroxyzine, as it can interact with other medications and can cause side effects.
1.
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma
2.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
3.
New research uncovers link between cancer pathway and blood-retina barrier function
4.
Lung cancer screening adherence rates decline annually after baseline screening
5.
Chromatin organization linked to p53 tumor suppression mechanism
1.
The Latest Research on Wiskott Aldrich Syndrome
2.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
3.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
4.
Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape
5.
Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
3.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation